Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05452902 · ClinicalTrials.gov registry record · Phase 2
Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT05452902 is a Phase 2 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 36 participants.
The verdict
NCT05452902, a Phase 2 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of platinum-based chemotherapy, often used to treat gastrointestinal cancers. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminary efficacy of exercise vs. nutrition education on CIPN, to systematically investigate the potential roles of inflammation and interoception, and to obtain data with a more accurate effect size to inform a future study.
Interventions
- BEHAVIORAL Nutrition Education
- BEHAVIORAL EXCAP Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-01-19 |
| Est. Completion | 2025-09-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05452902
The ClinicalTrials.gov registry entry for NCT05452902 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nutrition Education is the first listed.
NCT05452902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05452902 about?
NCT05452902 is a clinical study titled "Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21". Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of platinum-based chemotherapy, often used to treat gastrointestinal cancers. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminar...
What is the current status of trial NCT05452902?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2023-01-19. Estimated completion is 2025-09-25.
What interventions are being tested in trial NCT05452902?
The interventions under investigation include: Nutrition Education (BEHAVIORAL), EXCAP Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05452902?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.